title: Does post-artesunate delayed haemolysis change practice?
authors: J.D. MacLean Centre for Tropical Diseases, McGill University Health Centre, Montreal, Canada; Division of Infectious Diseases and Department of Medical Microbiology, McGill University Health Centre, Montreal, Canada.
authors: Cedric P
authors: CP
authors: Yansouni
authors: J.D. MacLean Centre for Tropical Diseases, McGill University Health Centre, Montreal, Canada; Division of Infectious Diseases and Department of Medical Microbiology, McGill University Health Centre, Montreal, Canada. Electronic address: michael.libman@mcgill.ca.
authors: Michael D
authors: MD
authors: Libman
mesh_terms: D000962:Antimalarials / Q000009:adverse effects* / Q000627:therapeutic use; D037621:Artemisinins / Q000009:adverse effects* / Q000627:therapeutic use; D000077332:Artesunate; D006461:Hemolysis; D006801:Humans; D008288:Malaria / Q000188:drug therapy*; D017410:Practice Guidelines as Topic
chemical_list: D000962:Antimalarials; D037621:Artemisinins; D000077332:Artesunate